Extracellular vesicles in heart failure

Adv Clin Chem. 2024:119:1-32. doi: 10.1016/bs.acc.2024.02.001. Epub 2024 Feb 24.

Abstract

Physiologically, extracellular vesicles (EVs) have been implicated as crucial mediators of immune response, cell homeostasis, angiogenesis, cell differentiation and growth, and tissue repair. In heart failure (HF) they may act as regulators of cardiac remodeling, microvascular inflammation, micro environmental changes, tissue fibrosis, atherosclerosis, neovascularization of plaques, endothelial dysfunction, thrombosis, and reciprocal heart-remote organ interaction. The chapter summaries the nomenclature, isolation, detection of EVs, their biologic role and function physiologically as well as in the pathogenesis of HF. Current challenges to the utilization of EVs as diagnostic and predictive biomarkers in HF are also discussed.

Keywords: Cardiac remodeling; Diagnostic value; Extracellular vesicles; Heart failure; Heart failure with mildly reduced ejection fraction; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Predictive value.

MeSH terms

  • Biomarkers
  • Extracellular Vesicles* / pathology
  • Fibrosis
  • Heart Failure* / diagnosis
  • Humans
  • Stroke Volume / physiology

Substances

  • Biomarkers